The aim of the study was to assess the relationship between the levels of sPD-1, sTIM-3 and sLAG-3 as well as Gal-3 in plasma and the degree of LF in patients with CHC, as well as to investigate the impact of effective DAA-based treatment on their levels. This evidence concerns the gene LAG3 and cryohydrocytosis.